1. Long-term diosmectite use does not alter the gut microbiota in adults with chronic diarrhea.
- Author
-
Da Silva, Kévin, Guilly, Susie, Thirion, Florence, Le Chatelier, Emmanuelle, Pons, Nicolas, Roume, Hugo, Quinquis, Benoît, Ehrlich, Stanislav D., Bekkat, Nassima, Mathiex-Fortunet, Hélène, Sokol, Harry, and Doré, Joël
- Subjects
- *
GUT microbiome , *SHOTGUN sequencing , *DIARRHEA , *CLAY , *ADULTS - Abstract
Background: Diosmectite, a natural colloidal clay, has been used worldwide for a number of approved indications, including the treatment of chronic functional diarrhea. Here, we used high-resolution whole metagenome shotgun sequencing to assess the impact of a 5 weeks administration of diosmectite (3 g/sachet, 3 sachets/day) on the fecal microbiota of 35 adults with functional chronic diarrhea. Results: Gut microbiota was not impacted by diosmectite administration. In particular, richness remained stable and no microbial species displayed a significant evolution. Segregating patients either by diosmectite response (non responder, early responder, late responder) or by nationality (Great-Britain or Netherlands) yielded the same results. Conclusion: We concluded that no microbiota-related physiological alterations are expected upon long-term treatment with diosmectite. Trial registration: Clinicaltrials.gov NCT03045926 [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF